NVCT
Price
$5.49
Change
+$0.03 (+0.55%)
Updated
Jan 17 closing price
Capitalization
106.07M
52 days until earnings call
RIGL
Price
$20.13
Change
+$2.78 (+16.02%)
Updated
Jan 17 closing price
Capitalization
354.59M
Ad is loading...

NVCT vs RIGL

Header iconNVCT vs RIGL Comparison
Open Charts NVCT vs RIGLBanner chart's image
Nuvectis Pharma
Price$5.49
Change+$0.03 (+0.55%)
Volume$34.92K
Capitalization106.07M
Rigel Pharmaceuticals
Price$20.13
Change+$2.78 (+16.02%)
Volume$584.55K
Capitalization354.59M
NVCT vs RIGL Comparison Chart
Loading...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVCT vs. RIGL commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVCT is a Hold and RIGL is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (NVCT: $5.49 vs. RIGL: $20.13)
Brand notoriety: NVCT and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NVCT: 22% vs. RIGL: 210%
Market capitalization -- NVCT: $106.07M vs. RIGL: $354.59M
NVCT [@Biotechnology] is valued at $106.07M. RIGL’s [@Biotechnology] market capitalization is $354.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVCT’s FA Score shows that 0 FA rating(s) are green whileRIGL’s FA Score has 0 green FA rating(s).

  • NVCT’s FA Score: 0 green, 5 red.
  • RIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, RIGL is a better buy in the long-term than NVCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVCT’s TA Score shows that 2 TA indicator(s) are bullish while RIGL’s TA Score has 5 bullish TA indicator(s).

  • NVCT’s TA Score: 2 bullish, 6 bearish.
  • RIGL’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RIGL is a better buy in the short-term than NVCT.

Price Growth

NVCT (@Biotechnology) experienced а -5.51% price change this week, while RIGL (@Biotechnology) price change was +23.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

NVCT is expected to report earnings on Mar 11, 2025.

RIGL is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RIGL($355M) has a higher market cap than NVCT($106M). RIGL YTD gains are higher at: 19.679 vs. NVCT (1.479). RIGL has higher annual earnings (EBITDA): 13.7M vs. NVCT (-20.26M). RIGL has more cash in the bank: 61.1M vs. NVCT (17.2M). RIGL has higher revenues than NVCT: RIGL (157M) vs NVCT (0).
NVCTRIGLNVCT / RIGL
Capitalization106M355M30%
EBITDA-20.26M13.7M-148%
Gain YTD1.47919.6798%
P/E RatioN/A74.56-
Revenue0157M-
Total Cash17.2M61.1M28%
Total DebtN/A60.2M-
FUNDAMENTALS RATINGS
RIGL: Fundamental Ratings
RIGL
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NVCTRIGL
RSI
ODDS (%)
Bearish Trend 5 days ago
88%
Bullish Trend 5 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
79%
Momentum
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
73%
MACD
ODDS (%)
N/A
Bullish Trend 5 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
87%
Bullish Trend 5 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
89%
Bearish Trend 5 days ago
86%
Advances
ODDS (%)
Bullish Trend 13 days ago
87%
Bullish Trend 16 days ago
83%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 20 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
89%
View a ticker or compare two or three
Ad is loading...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

NVCT and

Correlation & Price change

A.I.dvisor tells us that NVCT and KRYS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVCT and KRYS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCT
1D Price
Change %
NVCT100%
+0.55%
KRYS - NVCT
32%
Poorly correlated
+2.47%
RIGL - NVCT
29%
Poorly correlated
+16.02%
CSCI - NVCT
29%
Poorly correlated
+3.81%
PDSB - NVCT
28%
Poorly correlated
+1.40%
CELU - NVCT
27%
Poorly correlated
+4.55%
More

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been closely correlated with CLNN. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if RIGL jumps, then CLNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
+16.02%
CLNN - RIGL
92%
Closely correlated
-2.04%
HOOK - RIGL
91%
Closely correlated
+0.52%
DARE - RIGL
88%
Closely correlated
+0.30%
PHIO - RIGL
84%
Closely correlated
-4.81%
AZTR - RIGL
84%
Closely correlated
-8.18%
More